Pricing Log in Create free account

MiMedx Group, Inc (MDXG) vs Pharming Group N.V. Sponsored ADR (PHAR)

MiMedx Group, Inc and Pharming Group N.V. Sponsored ADR are both Biotechnology companies. MiMedx Group, Inc and Pharming Group N.V. Sponsored ADR are of similar size ($682.2M and $681.6M). Pharming Group N.V. Sponsored ADR trades at the lower P/E: 62.4× against 111×. Pharming Group N.V. Sponsored ADR grew revenue faster over the last twelve months: 7.85% against −2.36%. Pharming Group N.V. Sponsored ADR has the higher net margin (2.55% vs 1.76%) and the lower return on invested capital (5.50% vs 5.62%). Across the 22 metrics below, Pharming Group N.V. Sponsored ADR leads on 16 and MiMedx Group, Inc on 6.

Valuation

Metric MDXG PHAR Biotechnology median
P/E 110.75 62.40 8.50
P/S 1.84 1.36 9.71
P/B 3.03 1.85 2.13
Price to free cash flow 14.74 14.53 20.82
EV/EBITDA 26.27 14.36 0.64
EV/Sales 1.51 1.20 9.21
Earnings yield 0.90% 1.60% (33.15%)
Free cash flow yield 6.79% 6.88% (25.50%)

Profitability

Metric MDXG PHAR Biotechnology median
Gross margin 78.85% 86.54% 65.16%
Operating margin 2.46% 5.04% 0.00%
Net margin 1.76% 2.55% 0.00%
Free cash flow margin 12.51% 9.38% 0.00%
Return on equity 2.88% 3.67% (56.36%)
Return on assets 2.18% 2.05% (48.04%)
Return on invested capital 5.62% 5.50% 0.00%

Growth

Metric MDXG PHAR Biotechnology median
Revenue growth (TTM) (2.36%) 7.85% 6.02%
EPS growth (last fiscal year) 14.29% 125.00% 30.26%
Revenue growth, 5-year CAGR 11.02% 12.13% 9.41%
Net income growth, 5-year CAGR 0.00% (40.35%) 0.00%

Health

Metric MDXG PHAR Biotechnology median
Debt to equity 0.08 0.36 0.00
Current ratio 5.33 3.01 4.72
Net debt to EBITDA (1.88) (2.21) 0.96

Dividend

Metric MDXG PHAR Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric MDXG PHAR Biotechnology median
Market cap 682.15m 681.61m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack